Stay updated with breaking news from Nautilus Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vanguard Capital Wealth Advisors decreased its stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) by 13.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 40,000 shares of the company’s stock after selling 6,000 shares during the period. Vanguard Capital […]
After burning through $48m of Microsoft funding, the innovative AI platform developed by New York tech firm Nautilus Labs has been bought out by Danish technology provider Danelec
Seer (NASDAQ:SEER – Get Free Report) and Nautilus Biotechnology (NASDAQ:NAUT – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation. Earnings and Valuation This table compares Seer and […]
Vanguard Capital Wealth Advisors trimmed its position in Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) by 21.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 59,000 shares of the company’s stock after selling 16,500 shares during the quarter. Vanguard Capital Wealth Advisors’ holdings […]
Nautilus Biotechnology (NASDAQ:NAUT – Free Report) and Bio-Rad Laboratories (NYSE:BIO.B – Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings. Earnings and Valuation This table compares Nautilus Biotechnology and Bio-Rad […]